Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Waterboer

Showing results (331-340 of 431) with videos related to

Pageof 44
Sort By:
International Journal of Epidemiology|July 15, 2024
Prospective evaluation of the relevance of Epstein-Barr virus antibodies for early detection of nasopharyngeal carcinoma in Chinese adultsLing Yang, Christiana Kartsonaki, Julia Simon, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 14, 2019
Circulating Antibodies against Epstein-Barr Virus (EBV) and p53 in EBV-Positive and -Negative Gastric CancerM Constanza Camargo, Kyoung-Mee Kim, Keitaro Matsuo, et al.
Eclinicalmedicine|July 21, 2025
Erratum: Oral human papillomavirus (HPV) prevalence and genotyping among healthy adult populations in the United States and Europe: results from the PROGRESS (PRevalence of Oral hpv infection, a Global aSSessment) studyLaia Alemany, Marisa Felsher, Anna R Giuliano, et al.
Eclinicalmedicine|February 3, 2025
Oral human papillomavirus (HPV) prevalence and genotyping among healthy adult populations in the United States and Europe: results from the PROGRESS (PRevalence of Oral hpv infection, a Global aSSessment) studyLaia Alemany, Marisa Felsher, Anna R Giuliano, et al.
American Journal of Human Genetics|January 17, 2024
A common NFKB1 variant detected through antibody analysis in UK Biobank predicts risk of infection and allergyAmanda Y Chong, Nicole Brenner, Andres Jimenez-Kaufmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2016
Anoctamin 2 identified as an autoimmune target in multiple sclerosisBurcu Ayoglu, Nicholas Mitsios, Ingrid Kockum, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 25, 2020
Auto-antibodies to p53 and the Subsequent Development of Colorectal Cancer in a U.S. Prospective Cohort ConsortiumJulia Butt, William J Blot, Kala Visvanathan, et al.
Cancer|January 11, 2021
Timing, number, and type of sexual partners associated with risk of oropharyngeal cancerVirginia E Drake, Carole Fakhry, Melina J Windon, et al.
Medrxiv : the Preprint Server for Health Sciences|February 8, 2024
Blood-based screening for HPV-associated cancersDipon Das, Shun Hirayama, Ling Aye, et al.
Plos One|September 3, 2025
SARS-CoV-2 antibody and neutralization dynamics among persons with natural- and vaccine-induced exposuresChristopher S Semancik, Romain Fantin, Julia Butt, et al.
Pageof 44

Showing results (331-340 of 431) with videos related to

Sort By:
Pageof 44
International Journal of Epidemiology|July 15, 2024
Prospective evaluation of the relevance of Epstein-Barr virus antibodies for early detection of nasopharyngeal carcinoma in Chinese adultsLing Yang, Christiana Kartsonaki, Julia Simon, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 14, 2019
Circulating Antibodies against Epstein-Barr Virus (EBV) and p53 in EBV-Positive and -Negative Gastric CancerM Constanza Camargo, Kyoung-Mee Kim, Keitaro Matsuo, et al.
Eclinicalmedicine|July 21, 2025
Erratum: Oral human papillomavirus (HPV) prevalence and genotyping among healthy adult populations in the United States and Europe: results from the PROGRESS (PRevalence of Oral hpv infection, a Global aSSessment) studyLaia Alemany, Marisa Felsher, Anna R Giuliano, et al.
Eclinicalmedicine|February 3, 2025
Oral human papillomavirus (HPV) prevalence and genotyping among healthy adult populations in the United States and Europe: results from the PROGRESS (PRevalence of Oral hpv infection, a Global aSSessment) studyLaia Alemany, Marisa Felsher, Anna R Giuliano, et al.
American Journal of Human Genetics|January 17, 2024
A common NFKB1 variant detected through antibody analysis in UK Biobank predicts risk of infection and allergyAmanda Y Chong, Nicole Brenner, Andres Jimenez-Kaufmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2016
Anoctamin 2 identified as an autoimmune target in multiple sclerosisBurcu Ayoglu, Nicholas Mitsios, Ingrid Kockum, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 25, 2020
Auto-antibodies to p53 and the Subsequent Development of Colorectal Cancer in a U.S. Prospective Cohort ConsortiumJulia Butt, William J Blot, Kala Visvanathan, et al.
Cancer|January 11, 2021
Timing, number, and type of sexual partners associated with risk of oropharyngeal cancerVirginia E Drake, Carole Fakhry, Melina J Windon, et al.
Medrxiv : the Preprint Server for Health Sciences|February 8, 2024
Blood-based screening for HPV-associated cancersDipon Das, Shun Hirayama, Ling Aye, et al.
Plos One|September 3, 2025
SARS-CoV-2 antibody and neutralization dynamics among persons with natural- and vaccine-induced exposuresChristopher S Semancik, Romain Fantin, Julia Butt, et al.
Pageof 44